DSS, Inc. (DSS)

NYSEAMERICAN: DSS · Real-Time Price · USD
0.4663
-0.0057 (-1.21%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Market Cap4.68M -42.2%
Revenue (ttm)20.13M -0.2%
Net Income-24.97M
EPS-2.70
Shares Out 10.04M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume51,061
Open0.4900
Previous Close0.4720
Day's Range0.4618 - 0.4985
52-Week Range0.4613 - 1.8950
Beta1.00
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About DSS

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, a... [Read more]

Founded 1984
Employees 102
Stock Exchange NYSEAMERICAN
Ticker Symbol DSS
Full Company Profile

Financial Performance

In 2025, DSS, Inc.'s revenue was $20.76 million, an increase of 8.69% compared to the previous year's $19.10 million. Losses were -$23.93 million, -48.97% less than in 2024.

Financial Statements

News

DSS, Inc. Quarterly report: Q1 2026

DSS, Inc. has published its Q1 2026 quarterly earnings report on May 15, 2026.

20 days ago - Filings

DSS reports ‘going concern’ audit opinion in 2025 10-K filing

DSS (DSS) announced that its annual report for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes an audit opinion from HTL International LLC. that contains…

27 days ago - TheFly

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced that its annual report (10-K) for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes...

27 days ago - GlobeNewsWire

DSS, Inc. Registration statement: Registration filing

DSS, Inc. filed a registration statement on April 24, 2026, providing details about a securities offering with the SEC.

5 weeks ago - Filings

DSS, Inc. Registration statement: Registration filing

DSS, Inc. filed a registration statement on April 17, 2026, providing details about a securities offering with the SEC.

6 weeks ago - Filings

DSS, Inc. Annual report: Q4 2025

DSS, Inc. has published its Q4 2025 annual report on March 31, 2026.

2 months ago - Filings

DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, comm...

4 months ago - GlobeNewsWire

DSS prices 900,000 shares at $1.00 in underwritten public offering

DSS (DSS) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1M, before deducting underwriting fees and other offe...

4 months ago - TheFly

DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial le...

4 months ago - GlobeNewsWire

DSS, Inc. Announces Launch of Proposed Public Offering

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth inn...

4 months ago - GlobeNewsWire

DSS, Inc. Quarterly report: Q3 2025

DSS, Inc. has published its Q3 2025 quarterly earnings report on November 14, 2025.

7 months ago - Filings

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. filed a proxy statement on October 21, 2025, providing details for shareholder voting and corporate governance matters.

8 months ago - Filings

DSS, Inc. Proxy statement: Proxy Filing

DSS, Inc. filed a proxy statement on October 20, 2025, providing details for shareholder voting and corporate governance matters.

8 months ago - Filings

DSS, Inc. Quarterly report: Q2 2025

DSS, Inc. has published its Q2 2025 quarterly earnings report on August 14, 2025.

10 months ago - Filings

DSS’ Impact BioMedical announces strategic merger with Dr. Ashley’s

DSS (DSS) announced that its subsidiary, Impact BioMedical, has entered into a definitive merger agreement with Dr. Ashleys. Under the terms of the agreement, Dr. Ashleys will acquire Impact through…

1 year ago - TheFly

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, toda...

1 year ago - GlobeNewsWire

DSS, Inc. Quarterly report: Q1 2025

DSS, Inc. has published its Q1 2025 quarterly earnings report on May 15, 2025.

1 year ago - Filings

DSS, Inc. Annual report: Q4 2024

DSS, Inc. has published its Q4 2024 annual report on March 31, 2025.

1 year ago - Filings

DSS announces sale of Celios to Impact BioMedical

DSS (DSS) announced the sale of its Celios air purification asset to Impact BioMedical (IBO) in a strategic, all-equity transaction valued at approximately $1.15M. This divestiture aligns with DSS’ on...

Other symbols: IBO
1 year ago - TheFly

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air pur...

1 year ago - GlobeNewsWire

DSS interim CEO says immediate focus is to ‘optimize operational efficiencies’

DSS (DSS) issued the following letter to shareholders from interim CEO Jason Grady, which read in part, “As we embark on this new chapter, my immediate focus is to optimize…

1 year ago - TheFly

DSS, Inc. Issues Letter to Shareholders

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops asset...

1 year ago - GlobeNewsWire

LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #DocumentStorageSystems--LiveData and DSS advance operating room efficiency and patient access to surgery across 85% of VA Medical Centers with LiveData PeriOp Mana...

1 year ago - Business Wire

DSS, Inc. Quarterly report: Q3 2024

DSS, Inc. has published its Q3 2024 quarterly earnings report on November 14, 2024.

1 year ago - Filings

DSS, Inc. Registration statement: Registration Filing

DSS, Inc. filed a registration statement on October 31, 2024, providing details about a securities offering with the SEC.

1 year ago - Filings